Impact of Incorporation of Fibrinogen Concentrate in Blood Transfusion Management During Liver Transplantation: An Early Local (Single Centre) Experience

Figures & data

Table 1 Baseline Characteristics of Patients Who Received Fibrinogen Concentrate and Those Who Did Not

Characteristics	No Fibrinogen Concentrate (n=40)	With Fibrinogen Concentrate (n=14)	All (n=54)	P value
Male, n (%)	28 (70)	9 (64.3)	37 (68.5)	0.006*
Age, mean (SD), years	58 (8.48)	59 (5.01)	58 (7.71)	0.562
MELD at transplant	18.60 (6.97)	21.64 (8.57)	19.38 (7.45)	0.296
Preoperative Haemoglobin (g/dL)	10.87 (2.42)	9.33 (2.07)	10.47 (2.41)	0.039*
Preoperative INR	1.77 (2.08)	2.21 (2.35)	1.88 (2.14)	0.091

Table 2 Table Comparing Postoperative Blood Loss and Laboratory Values of Patients Who Received Fibrinogen Concentrate and Those Who Did Not

Characteristics	No Fibrinogen Concentrate (n=40)	With Fibrinogen Concentrate (n=14)	All (N=54)	P value
Blood loss (mL)	3230.02 (3716.56)	3337.35 (3620.79)	3480.07 (3658.84)	0.737
RCC (mL)	1629.85 (1848.94)	2458.64 (2494.84)	1844.72 (2043.69)	0.210
Plasma (mL)	2218.50 (1577.96)	2501.28 (1461.56)	2291.81 (1540.08)	0.559
Cryoprecipitate (mL)	134.30 (207.02)	8.71 (32.60)	101.74 (186.77)	0.002*
POD - Haemoglobin	8.99 (1.16)	9.35 (1.50)	9.08 (1.25)	0.358
POD - INR	1.29 (0.43)	1.54 (0.34)	1.35 (0.42)	0.183